Skip to content
Biotechnology News, Trends & Expert Insights

Our Latest

November 18, 2026

Also on the bench

  1. Optimi Health Outlines 2027 Plans for OPTI-101 Phase 2b in Major Depressive Disorder and OPTI-201 Phase 3 in PTSD; Announces Shares-for-Debt Settlement
  2. Mass photometry reaches 2,000-publication milestone as applications expand
  3. Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
  4. Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
  5. PacBio to Participate in the Piper Sandler 38th Annual Healthcare Conference
  6. Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
  7. CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  8. Global DNA Polymerase Market Report - 2026 Edition: Size, Share, Growth and Forecast to 2030 | Market to Reach US$2.85B as Genomics, Diagnostics and Synthetic Biology Accelerate
  9. Rat Models - Global Strategic Business Report 2026: Secure Share of a $2.9 Billion Market by 2032
  10. Veru Presents New Results at ObesityWeek 2026: GLP-1 Weight Loss in Older Adults Associated with Physical Function Decline; Adding Enobosarm Preserved Significant Lean Mass and Physical Function
  11. Nexentis: MitoCareX Progresses Toward In-Vitro Evaluation Following AI-Powered Computational Screening
  12. Insight Molecular Diagnostics Announces Pricing of $15 Million Public Offering
  13. BetterLife Pharma Announces Stock Option Grant
  14. BetterLife Pharma Announces New Preclinical Research Highlighting Neuroplasticity-Related Effects of Non-Hallucinogenic BETR-001 at Neuroscience 2026
  15. Senti Bio Announces Reverse Stock Split
  16. Thermosome Closes Exclusive Global Licensing Agreement with Avenor Therapeutics
  17. Mobile Apps for DNA Sequencing Market to Reach $2.4 Billion by 2031
  18. Kraig Biocraft Laboratories CEO Publishes Forbes Technology Council Article on the Future of Bio-Engineered Materials
  19. Zenas BioPharma Launches The Distance Between Platform to Bring Greater Visibility to the Hidden Burden of IgG4-Related Disease
View all Posts124 posts on Biotech News